Edition:
United States

Foundation Medicine Inc (FMI.OQ)

FMI.OQ on NASDAQ Stock Exchange Global Select Market

33.00USD
4:00pm EDT
Change (% chg)

$-0.50 (-1.49%)
Prev Close
$33.50
Open
$33.55
Day's High
$34.35
Day's Low
$32.95
Volume
48,508
Avg. Vol
63,628
52-wk High
$35.25
52-wk Low
$15.10

FMI.OQ

Chart for FMI.OQ

About

Foundation Medicine, Inc. is a molecular information company. The Company sells products that are enabled by its molecular information platform to physicians and biopharmaceutical companies. The Company's segment is the business of delivering molecular information about cancer to its customers. Its products provide genomic... (more)

Overall

Beta: -0.06
Market Cap(Mil.): $1,186.52
Shares Outstanding(Mil.): 35.42
Dividend: --
Yield (%): --

Financials

  FMI.OQ Industry Sector
P/E (TTM): -- 49.04 30.15
EPS (TTM): -3.25 -- --
ROI: -51.28 -2.17 13.05
ROE: -53.58 5.20 14.20

BRIEF-Foundation Medicine Q4 loss per share $1.02

* Foundation Medicine announces 2016 fourth quarter and year-end results, recent highlights and 2017 outlook

Feb 22 2017

BRIEF-Discovery Group I LLC reports 5.2 pct stake in Foundation Medicine as of Jan 19 - SEC Filing

* Discovery Group I LLC reports 5.2 percent stake in Foundation Medicine Inc as of Jan 19 - SEC Filing

Jan 30 2017

BRIEF-Foundation Medicine says Q3 loss per share $0.90

* Says co continues to expect 2016 revenue will be in range of $110 million to $120 million

Nov 02 2016

BRIEF-Foundation Medicine adds Life Sciences leader Michael Dougherty to its board of directors

* Foundation Medicine adds Life Sciences leader Michael R. Dougherty to its board of directors Source text for Eikon: Further company coverage:

Oct 27 2016

More From Around the Web

Earnings vs. Estimates